Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1998
05/12/1998CA2033277C Controlled release pharmaceutical preparation and method for producing the same
05/12/1998CA2012469C Polyurethanes
05/07/1998WO1998019311A1 Electrically conductive adhesive hydrogels
05/07/1998WO1998018849A1 Grafted rubber-like silicone gel with enhanced oil compatibility and its synthetic process
05/07/1998WO1998018827A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
05/07/1998WO1998018816A1 Peptide compositions with growth factor-like activity
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018501A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018498A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018497A2 Contrast agents
05/07/1998WO1998018496A2 Contrast agents
05/07/1998WO1998018495A2 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998WO1998018494A1 Methods for the synthesis of functionalizable poly(ethylene oxide) star macromolecules
05/07/1998WO1998018493A2 Conjugates useful in the treatment of prostate cancer
05/07/1998WO1998018492A1 Method of inhibiting drug precipitation
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018477A2 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998WO1998018463A1 Anthelmintic formulation
05/07/1998WO1998018455A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
05/07/1998WO1998018452A1 Soluble form osmotic dose delivery system
05/07/1998WO1998018451A2 Substituted amylose as a matrix for sustained drug release
05/07/1998WO1998018417A1 Fatty acid esters of lactic acid salts as permeation enhancers
05/07/1998WO1998018416A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers
05/07/1998WO1998008517A3 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
05/07/1998WO1998007415A3 Methods for prevention of cellular proliferation and restenosis
05/07/1998WO1998005363A3 Polypeptides having a single covalently bound n-terminal water-soluble polymer
05/07/1998WO1998005362A3 Protein-containing polymer composition for oral administration
05/07/1998WO1998005360A3 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes
05/07/1998WO1998004242A3 Tumor delivery vehicles and method to enhance treatment of cystic tumors
05/07/1998WO1998002189A3 Method for preparing bioactive polymers
05/07/1998WO1998000173A3 Targeted drug delivery using sulfonamide derivatives
05/07/1998WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/07/1998DE19645319A1 Foaming composition, useful as skin care medium e.g. as shaving foam
05/07/1998DE19645189A1 Geminitenside Gemini surfactants
05/07/1998CA2535449A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2270174A1 Pharmaceutical compositions containing lamivudine and zidovudine
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2268738A1 Conjugates useful in the treatment of prostate cancer
05/07/1998CA2263334A1 Fatty acid esters of lactic acid salts as permeation enhancers
05/07/1998CA2263300A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers
05/06/1998EP0839849A1 Process for producing a polyoxyalkylene derivative substituted with succinimidyl group
05/06/1998EP0839528A1 Mouth-soluble compositions containing N-acetylcysteine and cyclodextrin
05/06/1998EP0839525A1 Sustained-release preparation
05/06/1998EP0839125A1 Novel cationic lipids and the use thereof
05/06/1998EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
05/06/1998EP0839053A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
05/06/1998EP0839052A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases
05/06/1998EP0839049A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions
05/06/1998EP0839047A1 Pharmaceutical compositions containing protein
05/06/1998EP0839039A1 Paroxetine controlled release compositions
05/06/1998EP0839029A1 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
05/06/1998EP0839028A2 Pharmaceutical compositions
05/06/1998EP0839026A1 Polyether block copolymer micellar compositions for targeting biological agents
05/06/1998EP0839025A1 Lipid vehicle drug delivery composition containing vitamin e
05/06/1998EP0737062B1 Water-in-oil lotion containing a corticosteroid
05/06/1998EP0736044B1 Cyclodextrin derivatives for solubilising hydrophobic chemical compounds such as drugs, and methods for preparing same
05/06/1998EP0671908B1 Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers
05/06/1998EP0591452B1 Multiple emulsions and methods of preparation
05/06/1998CN1181060A Alk(En)yl dicarboxylic acid bisesters, their use and method for preparing them
05/06/1998CN1181007A Preparation for absorbing transmission from skin
05/06/1998CN1180711A Thioether conjugates
05/06/1998CN1180697A Cationic lipids for gene therapy
05/06/1998CN1180570A High polymer antineoplastic guide medicine and preparation method thereof
05/06/1998CN1180569A Preparation for medicine feeding through nose
05/05/1998US5747654 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
05/05/1998US5747646 Polyethylene-protein conjugates
05/05/1998US5747642 Monomeric insulin analog formulations
05/05/1998US5747641 Tat-derived transport polypeptide conjugates
05/05/1998US5747639 Use of hydrophobic interaction chromatography to purify polyethylene glycols
05/05/1998US5747471 Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
05/05/1998US5747464 Prevent absorption of fat and cholesterol
05/05/1998US5747456 Continuous low-dose administration of parathyroid hormone or its agonist
05/05/1998US5747447 Stable polypeptide composition
05/05/1998US5747445 Insulin with bile salts for enhancing absorption for breathing
05/05/1998US5747324 Plasmid vectors for insertion in dna for pox virus vectors, prokarotic origin and dna sequences
05/05/1998US5747297 Industrial pharmaceutical and cosmetics applications for cultured plant cell gums
05/05/1998US5747069 Monoglyceride and fatty acid promoters; tachykinin antagonists
05/05/1998US5747068 Flouxetine pharmaceutical formulations
05/05/1998US5747065 Monoglyceride/lactate ester permeation enhancer for oxybutynin
05/05/1998US5747064 Psoriasis treatment
05/05/1998US5747058 High viscosity liquid controlled delivery system
05/05/1998US5747030 Pharmaceutical preparation containing plasminogen activators
05/05/1998US5747026 Antioxidants
05/05/1998US5747001 Aerosols containing beclomethazone nanoparticle dispersions
05/05/1998CA2100126C 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
05/05/1998CA2097589C Targeting of therapeutic agents using polysaccharides
05/05/1998CA2087435C Use of interfacially-polymerized membranes in delivery devices
05/05/1998CA1339857C Monoclonal antibodies to gp120 which neutraleze hiv-1
04/1998
04/30/1998WO1998017818A1 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure
04/30/1998WO1998017806A1 Mini-e1a genes and gene products
04/30/1998WO1998017738A1 Collagen or gelatin crumble composition and uses
04/30/1998WO1998017693A1 Composition containing chitosan
04/30/1998WO1998017689A2 Il-12 gene expression and delivery systems and uses
04/30/1998WO1998017325A2 Covalent polar lipid conjugates for targeting
04/30/1998WO1998017320A1 Use of hyaluronan in gene therapy
04/30/1998WO1998017319A2 Platelet substitutes and conjugation methods suitable for their preparation
04/30/1998WO1998017318A1 Use of hollow microcapsules in diagnosis and therapy
1 ... 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 ... 1712